Combined evaluation of Rad51 and ERCC1 e
β
Tomoyoshi Takenaka; Ichiro Yoshino; Hidenori Kouso; Taro Ohba; Tomofumi Yohena;
π
Article
π
2007
π
John Wiley and Sons
π
French
β 679 KB
## Abstract DNA repair enzyme expression in tumor cells possibly affects sensitivity to antiβcancer agents. The aim of this study was to determine the relationship between expression status of DNA repair enzymes and chemosensitivity in patients with nonβsmall cell lung cancer (NSCLC). NSCLC tissues